Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Advaxis submits IND for Phase I/II trial of ADXS-HPV and MEDI4736 in HPV-associated cancers US-based biotechnology firm Advaxis has submitted an investigational new drug (IND) application to the US Food and Drug Administration (FDA) for its Lm-LLO immunotherapy ADXS-HPV (ADXS11-001) in combination with MEDI4736 to treat human papillomavirus (HPV) associated cancers. Production & Manufacturing > Process & Production > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
News

Process & Production

Highland Therapeutics receives second notice of allowance for patent on Lead product
Highland Therapeutics, a pharmaceutical company, announced that the US Patent and Trademark Office has issued a Notice of Allowance for a patent application for HLD-200, a novel formulation of methylphenidate designed to be taken once-daily in the evening with the objective of controlling symptoms of ADHD immediately upon awakening and throughout the day.
News
Sanofi and Regeneron's atopic dermatitis drug receives FDA breakthrough therapy status
By PBR Staff Writer
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Sanofi and Regeneron Pharmaceuticals' dupilumab to treat adults with moderate-to-severe atopic dermatitis (AD).
News

OTC

Dr. Reddy’s launches OTC Fexofenadine Hydrochloride 60 g and Pseudoephedrine Hydrochloride 120mg extended-release tablets
Dr. Reddy’s Laboratories has launched its over-the-counter (OTC) Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg, a bioequivalent generic version of Allegra-D® 12 Hour Allergy & Congestion, in the U.S. market on November 18, 2014.
News
Axxess Pharma gets approval to sell high potency Omega-3 fish oil supplement in Canada
By PBR Staff Writer
Axxess Pharma, through its subsidiary AllStar Health Brands has received approval from Health Canada to sell their high potency Omega-3 fish oil supplement across Canada.
News

Manufacturing

Abbvie expands capabilities in Asia with new manufacturing facility in Singapore
By PBR Staff Writer
US-based biopharmaceutical firm AbbVie has expanded its global operations for small molecule and biologics manufacturing by acquiring a small molecule active pharmaceutical ingredient (API) manufacturing site in Singapore's Tuas Biomedical Park.
News
AXIM to build manufacturing facility for hemp-based products in Netherlands
By PBR Staff Writer
AXIM Biotechnologies has selected the coastal city of Almere in the Netherlands, for its future hemp-based products manufacturing facility headquarters.
News